Colorectal cancer stem cells

Somatic stem cells reside at the base of the crypts throughout the colonic mucosa. These cells are essential for the normal regeneration of the colonic epithelium. The stem cells reside within a special ‘niche’ comprised of intestinal sub‐epithlial myofibroblasts that tightly control their function. It has been postulated that mutations within these adult colonic stem cells may induce neoplastic changes. Such cells can then dissociate from the epithelium and travel into the mesenchyme and thus form invasive cancers. This theory is based on the observation that within a colon cancer, less than 1% of the neoplastic cells have the ability to regenerate the tumour. It is this group of cells that exhibits characteristics of colonic stem cells. Although anti‐neoplastic agents can induce remissions by inhibiting cell division, the stem cells appear to be remarkably resistant to both standard chemotherapy and radiotherapy. These stem cells may therefore persist after treatment and form the nucleus for cancer recurrence. Hence, future treatment modalities should focus specifically on controlling the cancer stem cells. In this review, we discuss the biology of normal and malignant colonic stem cells.

[1]  H. Ueno,et al.  A New Prognostic Staging System for Rectal Cancer , 2004, Annals of surgery.

[2]  W. Thilly,et al.  Stem cell stages and the origins of colon cancer , 2007, Stem Cell Reviews.

[3]  H. Broxmeyer,et al.  Stem cells: shibboleths of development. , 2004, Stem cells and development.

[4]  A. Spradling,et al.  Stem cells find their niche , 2001, Nature.

[5]  Rolf Bjerkvig,et al.  The origin of the cancer stem cell: current controversies and new insights , 2005, Nature Reviews Cancer.

[6]  Rolf Bjerkvig,et al.  Opinion: the origin of the cancer stem cell: current controversies and new insights. , 2005, Nature reviews. Cancer.

[7]  T. Sun,et al.  Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. , 2005, Biochimica et biophysica acta.

[8]  W. Thilly,et al.  Bell-shaped nuclei dividing by symmetrical and asymmetrical nuclear fission have qualities of stem cells in human colonic embryogenesis and carcinogenesis. , 2006, Cancer genetics and cytogenetics.

[9]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[10]  P. Laird,et al.  Epigenetic stem cell signature in cancer , 2007, Nature Genetics.

[11]  Faith Davis,et al.  Brain tumor survival: Results from the National Cancer Data Base , 1998, Journal of Neuro-Oncology.

[12]  R. Hill Identifying cancer stem cells in solid tumors: case not proven. , 2006, Cancer research.

[13]  Hans Clevers,et al.  Self-Renewal and Cancer of the Gut: Two Sides of a Coin , 2005, Science.

[14]  C. Potten,et al.  The intestinal epithelial stem cell: the mucosal governor , 1997, International journal of experimental pathology.

[15]  S. Tavaré,et al.  Enhanced stem cell survival in familial adenomatous polyposis. , 2004, The American journal of pathology.

[16]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[17]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[18]  P. Lian,et al.  Prediction of Treatment Outcome by CD44v6 After Total Mesorectal Excision in Locally Advanced Rectal Cancer , 2008, Cancer journal.

[19]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[20]  R. Glynne-Jones,et al.  Complete Clinical Response After Preoperative Chemoradiation in Rectal Cancer: Is a “Wait and See” Policy Justified? , 2008, Diseases of the colon and rectum.

[21]  Kyoung-Mee Kim,et al.  Methylation reveals a niche: stem cell succession in human colon crypts , 2002, Oncogene.

[22]  Ana M Soto,et al.  Theories of carcinogenesis: an emerging perspective. , 2008, Seminars in cancer biology.

[23]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[24]  D. Powell Intestinal subepithelial myofibroblasts , 1999 .

[25]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[26]  A B West,et al.  Myofibroblasts. II. Intestinal subepithelial myofibroblasts. , 1999, American journal of physiology. Cell physiology.

[27]  S. Kirkland Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium , 1988, Cancer.

[28]  M. Ocker,et al.  Gastrointestinal cancer - only a deregulation of stem cell differentiation? (Review). , 2006, International journal of molecular medicine.

[29]  Y. Allory,et al.  Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer. , 2006, Surgery.

[30]  N. Wright,et al.  Mechanisms of Disease: from stem cells to colorectal cancer , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[31]  Kelly M. McGarvey,et al.  A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.

[32]  Mina J Bissell,et al.  Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.

[33]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[34]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[35]  M. Wicha,et al.  Symmetric Division of Cancer Stem Cells – a Key Mechanism in Tumor Growth that should be Targeted in Future Therapeutic Approaches , 2007, Clinical pharmacology and therapeutics.

[36]  N. Wright,et al.  The gastrointestinal stem cell , 2004, Cell proliferation.

[37]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[38]  H. Ueno,et al.  Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer , 2002, Histopathology.